Silence Therapeutics (SLN) Non-Current Assets (2019 - 2025)
Historic Non-Current Assets for Silence Therapeutics (SLN) over the last 7 years, with Q3 2025 value amounting to $13.2 million.
- Silence Therapeutics' Non-Current Assets fell 1469.14% to $13.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.2 million, marking a year-over-year decrease of 1469.14%. This contributed to the annual value of $15.3 million for FY2024, which is 631.37% down from last year.
- Silence Therapeutics' Non-Current Assets amounted to $13.2 million in Q3 2025, which was down 1469.14% from $16.7 million recorded in Q2 2025.
- In the past 5 years, Silence Therapeutics' Non-Current Assets ranged from a high of $16.7 million in Q2 2025 and a low of $12.5 million during Q3 2022
- For the 5-year period, Silence Therapeutics' Non-Current Assets averaged around $14.1 million, with its median value being $13.3 million (2021).
- As far as peak fluctuations go, Silence Therapeutics' Non-Current Assets skyrocketed by 2525.96% in 2023, and later crashed by 1469.14% in 2025.
- Silence Therapeutics' Non-Current Assets (Quarter) stood at $13.3 million in 2021, then fell by 4.58% to $12.7 million in 2022, then increased by 25.26% to $15.9 million in 2023, then fell by 3.9% to $15.3 million in 2024, then dropped by 13.83% to $13.2 million in 2025.
- Its Non-Current Assets stands at $13.2 million for Q3 2025, versus $16.7 million for Q2 2025 and $15.5 million for Q1 2025.